We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+5.29%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$39.5B
AUM Growth
+$3.17B
(+8.7%)
Cap. Flow
+$1.77B
Cap. Flow
% of AUM
4.5%
Top 10 Holdings %
Top 10 Hldgs %
14.6%
Holding
2,920
New
47
Increased
1,798
Reduced
994
Closed
66
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$26.1M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$22M |
| 3 |
Apple
AAPL
|
+$20.6M |
| 4 |
Microsoft
MSFT
|
+$18.3M |
| 5 |
AT&T
T
|
+$15.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LNKD
LinkedIn Corporation
LNKD
|
+$24.4M |
| 2 |
Procter & Gamble
PG
|
+$21.2M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$19.7M |
| 4 |
Alcoa
AA
|
+$17.9M |
| 5 |
Yum! Brands
YUM
|
+$15.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.57% |
| 2 | Technology | 14.46% |
| 3 | Healthcare | 12.77% |
| 4 | Industrials | 10.91% |
| 5 | Consumer Discretionary | 9.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRLN
2551
DELISTED
Marlin Business Services Corp
MRLN
| $262K | ﹤0.01% |
12,515
-3,264
| -21% | -$64.7K |
|
2552
Omega Flex
OFLX
$297M
| $261K | ﹤0.01% |
+4,684
| New | +$205K |
|
2553
Rigel Pharmaceuticals
RIGL
$681M
| $260K | ﹤0.01% |
10,938
-1,353
| -11% | -$38.8K |
|
|
ASCMA
2554
DELISTED
Ascent Capital Group, Inc. Series A
ASCMA
| $260K | ﹤0.01% |
16,006
-1,366
| -8% | -$27K |
|
|
LJPC
2555
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $260K | ﹤0.01% |
14,840
+1,025
| +7% | +$19.6K |
|
2556
Agilysys
AGYS
$2.97B
| $259K | ﹤0.01% |
25,031
-602
| -2% | -$6.21K |
|
2557
Johnson Outdoors
JOUT
$491M
| $259K | ﹤0.01% |
6,534
-990
| -13% | -$38.2K |
|
2558
Nutanix
NTNX
$16B
| $259K | ﹤0.01% |
+9,744
| New | +$291K |
|
|
FRBK
2559
DELISTED
Republic First Bancorp Inc
FRBK
| $259K | ﹤0.01% |
31,001
+1,908
| +7% | +$10.5K |
|
2560
Evolution Petroleum
EPM
$132M
| $258K | ﹤0.01% |
25,829
-6,536
| -20% | -$54.8K |
|
|
CNBKA
2561
DELISTED
Century Bancorp Inc/Mass
CNBKA
| $256K | ﹤0.01% |
4,273
-315
| -7% | -$16.4K |
|
|
FMI
2562
DELISTED
Foundation Medicine, Inc.
FMI
| $256K | ﹤0.01% |
14,490
+1,538
| +12% | +$33.1K |
|
|
SIGM
2563
DELISTED
Sigma Designs Inc
SIGM
| $255K | ﹤0.01% |
42,481
-8,486
| -17% | -$61K |
|
|
JIVE
2564
DELISTED
Jive Software, Inc.
JIVE
| $255K | ﹤0.01% |
58,553
+11,032
| +23% | +$44.6K |
|
|
ARC
2565
DELISTED
ARC Document Solutions, Inc.
ARC
| $255K | ﹤0.01% |
50,213
-11,224
| -18% | -$47K |
|
|
XTLY
2566
DELISTED
Xactly Corporation
XTLY
| $255K | ﹤0.01% |
23,214
+4,580
| +25% | +$59.8K |
|
|
AC
2567
DELISTED
Associated Capital Group
AC
| $254K | ﹤0.01% |
7,771
-414
| -5% | -$14K |
|
|
BBBY
2568
Bed Bath & Beyond
BBBY
$481M
| $254K | ﹤0.01% |
19,284
+380
| +2% | +$4.67K |
|
2569
Evolent Health
EVH
$348M
| $254K | ﹤0.01% |
17,188
+531
| +3% | +$10.5K |
|
2570
eHealth
EHTH
$42.2M
| $253K | ﹤0.01% |
23,797
+1,670
| +8% | +$17K |
|
|
SGMO
2571
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $252K | ﹤0.01% |
82,533
+5,330
| +7% | +$19.4K |
|
|
TNAV
2572
DELISTED
Telenav Inc.
TNAV
| $252K | ﹤0.01% |
35,682
+3,283
| +10% | +$20K |
|
2573
Sportsman's Warehouse
SPWH
$44.5M
| $251K | ﹤0.01% |
26,750
+2,352
| +10% | +$22.3K |
|
|
LUMO
2574
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $251K | ﹤0.01% |
2,717
+79
| +3% | +$8.9K |
|
|
QHC
2575
DELISTED
Quorum Health Corporation
QHC
| $251K | ﹤0.01% |
34,507
-8,238
| -19% | -$49.6K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2016 Portfolio in Review
As of Q4 2016, RhumbLine Advisers held 2,920 positions worth $39.5B, up 8.7% from $36.3B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.77B of net new capital in Q4 2016, opening 47 new positions and adding to 1,798 existing holdings. Its largest new stake was Howmet Aerospace: 952,104 shares worth $13.5M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Procter & Gamble, an estimated $21.2M trimmed.
- RhumbLine Advisers's largest Q4 2016 buy was Howmet Aerospace: 952,104 shares worth $13.5M.
- RhumbLine Advisers added most to ExxonMobil in Q4 2016, an estimated $26.1M increase.
- RhumbLine Advisers's biggest Q4 2016 reduction was Procter & Gamble, cutting an estimated $21.2M.
- RhumbLine Advisers fully exited LinkedIn Corporation in Q4 2016, selling an estimated $24.4M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $39.5B portfolio in Q4 2016.
- RhumbLine Advisers opened 47 new positions and closed 66 in Q4 2016.
- RhumbLine Advisers's portfolio value rose 8.7% quarter-over-quarter to $39.5B.
Based on RhumbLine Advisers's 13F filing for Q4 2016, filed 27 Jan 2017.